Performance analysis of KalVista Pharmaceuticals (KALV)
Annual Return
Over the past 3 years, KALV has had an average annual return of +39.19%, outperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, KALV has had an average annual return of +0.39%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, KALV has had an average annual return of +3.38%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Apr 9, 2015, KALV has had an average annual return of -9.07%, underperforming the benchmark SPY, which returned +14.07% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +66.84% | +90.72% | -30.88% | +81.34% | -48.94% | -30.33% | +6.64% | -9.81% | +102.47% | +38% | -86.05% | -34.89% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.37% | +4.29% | +23.67% | +32.44% | +0.79% | +0.29% | +66.84% | ||||||
| 2025 | +5.24% | +27.86% | +1.30% | +19.29% | -14.30% | -4.22% | +20.59% | -1.26% | -9.49% | -10.42% | +32.60% | +11.62% | +90.72% |
| 2024 | +28.72% | -13.43% | -13.11% | -4.33% | +2.81% | +0.93% | +23.46% | -7.92% | -13.49% | -11.36% | -2.05% | -15.79% | -30.88% |
| 2023 | +17.86% | -7.92% | +7.22% | +8.51% | +14.32% | -7.74% | +12.28% | +7.40% | -11.26% | -11.80% | -0.64% | +45.20% | +81.34% |
| 2022 | -4.65% | +27.21% | -8.15% | -13.67% | -30.15% | +10.68% | +25.55% | +33.33% | -11.91% | -65.08% | +6.30% | +25.43% | -48.94% |
| 2021 | -19.96% | +116.23% | -21.86% | -2.79% | +8.14% | -11.27% | -15.95% | +1.51% | -14.62% | +3.03% | -19.35% | -8.75% | -30.33% |
| 2020 | -14.07% | -12.11% | -43.11% | +42.62% | +3.07% | +7.54% | -18.73% | +33.25% | -3.92% | +36.73% | +8.73% | +1.50% | +6.64% |
| 2019 | -5.36% | +21.37% | +26.18% | -19.64% | -7.61% | +4.25% | -25.12% | -5.82% | -25.76% | -8.59% | +36.56% | +23.01% | -9.81% |
| 2018 | +7.02% | -0.45% | -8.76% | +1.48% | -9.87% | -6.37% | +15.34% | +82.63% | +29.27% | -14.51% | +27.31% | -17.92% | +102.47% |
| 2017 | -0.55% | +4.32% | +6.48% | -4.09% | -2.81% | +1.18% | -1.69% | -8.71% | +1.88% | +89.02% | -22.14% | -1.57% | +38% |
Drawdown analysis of KalVista Pharmaceuticals (KALV)
The maximum drawdown for the KALV was -96.68%, occurring on Oct 19, 2022. This drawdown has not yet recovered.
The current KALV drawdown is -78.71%.
Since Apr 9, 2015 KALV has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.68% | Jun 8, 2015 | 1856 | Oct 19, 2022 | Ongoing | Ongoing | Ongoing |
| -33.33% | Apr 23, 2015 | 5 | Apr 30, 2015 | 11 | May 15, 2015 | 16 |
| -9.35% | Apr 9, 2015 | 2 | Apr 13, 2015 | 2 | Apr 15, 2015 | 4 |
| -7.01% | May 15, 2015 | 2 | May 19, 2015 | 10 | Jun 3, 2015 | 12 |
| -5.13% | Apr 21, 2015 | 1 | Apr 22, 2015 | 1 | Apr 23, 2015 | 2 |
| -3.92% | Apr 15, 2015 | 1 | Apr 16, 2015 | 1 | Apr 17, 2015 | 2 |